Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...

Myanmar has become the world's top source of illicit opium, surpassing Afghanistan due to its ongoing civil war and economic crisis. This s...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

India and Switzerland are boosting science and technology ties, combining India's scale with Swiss innovation for citizen solutions and sta...

Manipur Chief Minister Yumnam Khemchand Singh revealed that drug trafficking routes have shifted significantly post-2023 crisis, largely di...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

India's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...

Global markets are gaining traction as geopolitical worries ease and AI companies report strong earnings. Matt Orton of Raymond James highl...

South Korea remains in the emerging-market category as MSCI cites persistent foreign exchange market accessibility issues. Despite ongoing ...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...